ctrl K

Watchlist Price Alert

Infinity Pharmaceuticals ... (INFI)

NASDAQ: INFI · Real-Time Price · USD

0.01

-0.01 (-40.48%)

At close: Sep 29, 2023, 7:59 PM

Infinity Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	2.59M	1.86M	1.72M	3.05M	22.15M	6M	18.72M
Cost of Revenue	1.56M	1.12M	1.04M	7.31M	69K	n/a	n/a
Gross Profit	1.03M	738K	682K	-4.26M	22.08M	6M	18.72M
Operating Income	-44.84M	-45.08M	-38.5M	-45.66M	-11.93M	-36.45M	-30.89M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-44.37M	-45.26M	-40.49M	-47.11M	-11.25M	-42.55M	-30.1M
Net Income	-43.26M	-45.44M	-42.94M	-47.06M	-11.25M	-41.83M	-30.1M
Selling & General & Admin	13.46M	14.17M	12.42M	14.29M	14.25M	21.61M	42.22M
Research & Development	32.41M	31.65M	26.76M	27.12M	19.76M	20.83M	119.61M
Other Expenses	1.56M	1.12M	1.04M	7.31M	69K	-6.88M	n/a
Operating Expenses	45.87M	45.82M	39.18M	41.41M	34.01M	42.45M	161.83M
Interest Expense	180K	180K	2.44M	2.56M	93K	1.01M	1.23M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	47.44M	46.94M	40.22M	48.71M	34.08M	42.45M	161.83M
Income Tax Expense	-1.11M	180K	2.44M	-54K	769K	-720K	-2.19M
Shares Outstanding (Basic)	89.25M	85.6M	59.86M	56.98M	55.41M	50.56M	49.61M
Shares Outstanding (Diluted)	89.25M	85.6M	59.86M	56.98M	55.41M	50.56M	49.61M
EPS (Basic)	-0.48	-0.53	-0.72	-0.83	-0.2	-0.83	-0.61
EPS (Diluted)	-0.48	-0.53	-0.72	-0.83	-0.2	-0.83	-0.61
EBITDA	-44.84M	-44.6M	-38.01M	-45.66M	-11.74M	-43.33M	-30.89M
EBIT	-44.19M	-45.08M	-38.05M	-44.55M	-11.16M	-41.54M	-28.88M
Depreciation & Amortization	458K	480K	483K	219K	191K	1.72M	3.42M